Amerisource Health Services LLC recalls glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American He…
- Recall date
- December 17, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0202-2025
- FDA classification
- Class II
- Brand / firm
- Amerisource Health Services LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Failed Dissolution Specifications:
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
Get recall alerts
Free email alert whenever Amerisource Health Services LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Amerisource Health Services LLC